1 tracked superinvestor hold ARTIVA BIOTHERAPEUTICS INC (ARTV), worth $25M combined, led by Andreas Halvorsen. Smart money is accumulating ARTV as of the latest 13F filings.
Current price
$11.19
Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer. Its flagship therapeutic candidate, AB-101, is an innovative, ready-to-use (off-the-shelf) NK cell therapy. This treatment is being developed for a broad spectrum of…
Market cap
$267M
P/E
-3.15
Div yield
—
Revenue YoY
—
Analyst target
—
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$25M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating ARTV: 1 funds added or opened versus 0 trimming. 1 opened a brand-new position.
ARTIVA BIOTHERAPEUTICS INC (ARTV) is held by 1 tracked funds worth $25M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Andreas Halvorsen at 0.1% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
This quarter 1 fund opened a brand-new position (Andreas Halvorsen), with 0 adding and 0 trimming — a net accumulation signal.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| New buy | 0.1% | $25M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own ARTV?
1 tracked funds hold ARTIVA BIOTHERAPEUTICS INC (ARTV), the largest being Andreas Halvorsen (Viking Global Investors) at 0.1% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling ARTV?
In the most recent 13F quarter, 1 tracked fund added or opened ARTV and 0 trimmed it, including 1 brand-new position.
How much ARTV do tracked funds hold?
Combined disclosed long exposure to ARTV across tracked superinvestors is $25M as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.